Skip to main content
Premium Trial:

Request an Annual Quote

China's Gene Company to Market, Distribute eGene's Genetic Analyzer

NEW YORK (GenomeWeb News) — Hong-Kong-based Gene Company will market and distribute eGene’s HAD-GT12 system in China for three years, eGene said last week.
 
EGene said the genetic analysis tool uses capillary electrophoresis, microfluidics, liquid handling, and automation to “detect, quantify, identify and characterize DNA and RNA.”
 
Gene Company sells through a Foreign Invested Commercial Enterprise company to research institutes, hospitals and industrial plants, and to genomics and proteomics research centers.
 
Financial terms of the agreement were not released.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.